Clinical Trial Update: Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients [Phase 1]

View source ↗

Summary

Phase I clinical protocol update assessing the pre-evaluation safety of BCG-PPD in tuberculosis patients; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BCG-PPD (Purified protein derivative of Bacillus Calmette-Guérin (BCG))

Snippet

Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Conditions: Tuberculosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING